The Effect of Electronic Cigarette Liquid Characteristics in Smokers.

Not Applicable

Completed

Conditions: Electronic Cigarettes

Registration Number: NCT03861078

Lead Sponsor: Virginia Commonwealth University

Brief Summary: The purpose of this study is to determine differences in nicotine delivery, user behaviors, subjective effects, and physiological effects, when cigarette smokers use an electronic cigarette with different nicotine (and sweetener) concentrations relative to using their own brand of cigarettes.

Detailed Description: Not available

Recruitment & Eligibility

Status: COMPLETED

Sex: All

Target Recruitment: 22

Inclusion Criteria

Not provided

Exclusion Criteria

Women if they are breast-feeding or test positive for pregnancy (by urinalysis) at screening.
Individuals who weigh less than 110 pounds.

Some study details about the eligibility criteria are purposely omitted at this time to preserve scientific integrity. Full details will be posted at the conclusion of the study.

Study & Design

Study Type: INTERVENTIONAL

Study Design: CROSSOVER

Primary Outcome Measures

Name	Time	Method
Progressive Ratio Task - Breakpoint	This task will begin approximately an hour and ten minutes after the 10-puff directed product use bout.	The progressive ratio task (PRT) is a self-administration task that will take 30-minutes to complete. It will begin by requiring ten computer key presses to earn the first puff of the session product, and this requirement will increase by 30% (i.e., 10, 13, 17, etc.) after each reinforcer (puff) is earned and consumed. The PRT will have three outcome measures (1) breakpoint (maximum number of key presses completed to earn a puff), (2) number of puffs, and (3) latency (sec) to initiate key pressing. Breakpoint is reported here.
Plasma Nicotine Concentration	Blood will be taken 4 times in each session to examine changes from baseline (approx 70 minutes) to immediately following a ten-puff bout (approx 80 minutes), and immediately before (approx 140 minutes) and after the PRT (approx 180 minutes).	Change in plasma nicotine concentration. Changes in plasm nicotine concentration during puff bout are considered to be the more relevant and accurate values so analysis and results reporting will focus on change from baseline to immediately following 10-puff bout.
Progressive Ratio Task - Number of Puffs	This task will begin approximately an hour and ten minutes after the 10-puff directed product use bout.	The progressive ratio task (PRT) is a self-administration task that will take 30-minutes to complete. It will begin by requiring ten computer key presses to earn the first puff of the session product, and this requirement will increase by 30% (i.e., 10, 13, 17, etc.) after each reinforcer (puff) is earned and consumed. The PRT will have three outcome measures (1) breakpoint (maximum number of key presses completed to earn a puff), (2) number of puffs, and (3) latency (sec) to initiate key pressing. Number of puffs is reported here.
Progressive Ratio Task - Latency	This task will begin approximately an hour and ten minutes after the 10-puff directed product use bout.	The progressive ratio task (PRT) is a self-administration task that will take 30-minutes to complete. It will begin by requiring ten computer key presses to earn the first puff of the session product, and this requirement will increase by 30% (i.e., 10, 13, 17, etc.) after each reinforcer (puff) is earned and consumed. The PRT will have three outcome measures (1) breakpoint (maximum number of key presses completed to earn a puff), (2) number of puffs, and (3) latency (milliseconds) to initiate key pressing. Latency is reported here.

Secondary Outcome Measures

Name	Time	Method
Puff Duration	The duration of each puff will be measured during the approximately 5-minute, 10-puff use bout.	The duration of each puff, in seconds, averaged over the 10-puff use bout
Puff Volume	Puff volume will be measured during the approximately 5-minute, 10-puff use bout.	The volume of each puff, in ml, averaged over the 10-puff use bout

Trial Locations

Locations (1): Clinical Behavioral Pharmacology Laboratory
🇺🇸
Richmond, Virginia, United States
Clinical Behavioral Pharmacology Laboratory
🇺🇸Richmond, Virginia, United States